Both in Pharmaceuticals
Bausch Health Companies vs Amylyx Pharmaceuticals
Over the past year BHC returned +43.2% and AMLX returned +106.8%; their daily moves had a correlation of 0.10.
BHC +43.2% AMLX +106.8%Growth of $1, one year, split-adjusted
| Metric | BHC | AMLX |
|---|---|---|
| Price | $8.45 | $28.73 |
| Market cap | $3.16B | $3.61B |
| Today | −5.16% | +0.17% |
| 1 month | +47.5% | +2.3% |
| 6 months | +49.6% | +79.5% |
| Year to date | +21.6% | +137.8% |
| 1 year | +43.2% | +106.8% |
| Revenue growth (YoY) | +9.7% | — |
| Gross margin | 75.0% | — |
| Net margin | 14.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | — |
| Net cash | -$18.15B | $250.8M |
| Dividend yield | — | — |
| Volatility (60d) | 67.0% | 112.7% |
| Short % of float | 3.1% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).